Sarcomatrix Therapeutics Corp — Form C-U (Regulation Crowdfunding)
Sarcomatrix Therapeutics Corp of RENO, NV filed a Form C-U (Regulation Crowdfunding) with the SEC on 2024-08-13. Target raise $15K, up to $1.2M. Offered through StartEngine Capital, LLC.
Offering
- Filed: 2024-08-13
- Form: C-U
- Accession: 0001665160-24-001175
- Target amount: $15K
- Maximum amount: $1.2M
- Security type: Common Stock
- Securities offered: 6,000
- Price: $2.5000
- Deadline: 2024-07-29
- Funding portal / intermediary: StartEngine Capital, LLC
- Intermediary file number: 007-00007
Issuer
- CIK: 0002017651
- Website: http://www.sarcomatrix.com
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2022-05-20
- Address: 450 SINCLAIR ST, RENO, NV, 89501
- Employees: 4
Financials (as filed)
- Total assets (most recent): $37K
- Cash (most recent): $37K
- Net income (most recent): $-103K
- Short-term debt: $19K
- Long-term debt: $113K
People (7)
| Name | Role | Location |
|---|
| Michael Hitchcock | Director | King City, CA |
| David Craig | CEO | London, X0 |
| David Craig | CEO, President, Chairman, Principal Accounting Officer | London, X0 |
| Dean Burkin | Director | RENO, NV |
| Dean Josef Burkin | Board Member | RENO, NV |
| Ryan David Wuebbles | CSO | RENO, NV |
| Michael J.M. Hitchcock | Board Member | RENO, NV |
Reg CF filing history (5)
More